New study shows AI alerts help more heart patients get life-saving valve disease care

Black doctor listening senior man's heartbeat during home visit. Focus is on senior man.

A major new national study led by Inova cardiologist Wayne Batchelor, MD, MHS, MBA, shows that artificial intelligence (AI) can help doctors find and treat serious heart valve disease sooner – especially for patients who are frequently undertreated, despite availability of effective valve therapies. Dr. Batchelor, an interventional cardiologist and President of Inova’s Medicine Service…

Read More

Inova among first hospitals to introduce leading-edge treatment for blocked or narrowed coronary artery stents

Cardiac catheterization and placement of cardiac stents is a highly effective, common procedure to treat blockage of the coronary artery. It uses a tiny, metal frame tube to reopen the artery and restore blood flow to the heart. Even though it is performed fairly frequently, the procedure isn’t without risk. In roughly 10% of cases…

Read More

Inova Study Offers New Treatment for Tricuspid Valve Regurgitation

Wayne Batchelor, MD, is Director of Interventional Cardiology and Interventional Cardiology Research at the Inova Heart and Vascular Institute. His outpatient practice is based at the Inova Cardiology Fairfax office. He is board-certified in cardiovascular disease with added qualifications in interventional cardiology. Tricuspid valve regurgitation is a relatively common problem. Millions of Americans have the condition, which is caused…

Read More

Health Disparities in Aortic Stenosis: Closing the Treatment Gap

Wayne Batchelor, MD, is Director of Interventional Cardiology and Interventional Cardiology Research at the Inova Heart and Vascular Institute. He is board-certified in cardiovascular disease with added qualifications in interventional cardiology. Aortic stenosis is one of the most common diseases affecting the heart valves. It’s life-threatening, but also highly treatable. Yet many people with aortic…

Read More